Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0354720070310020144
Journal of Korean Diabetes Association
2007 Volume.31 No. 2 p.144 ~ p.150
Transforming Growth Factor-beta 1 Gene Polymorphisms According to Diabetic Nephropathy in Type 2 Diabetes
Jeon Hwang-Gyun

Kim Ok-Hee
Kim Ho
Kwon Soon-Kil
Oh Tae-Geun
Abstract
Background: Transforming growth factor-¥â is known to play a role in the interaction between metabolic and hemodynamic factors in mediating accumulation of extracellular matrix in the diabetic nephropathy. TGF-¥â1 gene polymorphism was associated with circulating TGF-¥â levels and influenced the pathogenesis of fibrotic diseases including diabetic nephropathy. In this study, we examined the relationship between TGF-¥â1 gene codon 10 polymorphism and type 2 diabetic nephropathy with more than 10-year history of disease.

Methods: We conducted a case-control study, which enrolled 325 type 2 diabetes. A total of 176 patients with diabetic nephropathy were compared with 149 patients without diabetic nephropathy. TGF-¥â1 codon 10 genotyping was determined using polymerase chain reaction with sequence specific primers method.

Results: Distribution of TGF-¥â1 codon 10 genotype in the patients either with nephropathy or without nephropathy is confined to Hardy-Weinberg equilibrium. The patients with nephropathy have higher frequency of TGF-¥â1 GA/GG genotypes than the patients without nephropathy [GA/GG:AA = 119 (67.6%) : 57 (32.4%) vs. 80 (53.7%) : 69 (46.3%), P < 0.05]. Among patients with diabetic nephropathy, those with TGF-¥â1 GA/GG genotypes had higher serum levels of total cholesterol and LDL-cholesterol.

Conclusion: Our results suggest that TGF-¥â1 gene codon 10 polymorphism may contribute to the type 2 diabetic nephropathy.
KEYWORD
Diabetic nephropathy, TGF-¥â1 polymorphism, Type 2 diabetes
FullTexts / Linksout information
Listed journal information
KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø